Garrido-Cumbrera, Marco
,
Poddubnyy, Denis
Gossec, Laure
Gálvez-Ruiz, David
Bundy, Christine
Mahapatra, Raj
Makri, Souzi
Christen, Laura
Delgado-Domínguez, Carlos J.
Sanz-Gómez, Sergio
Plazuelo-Ramos, Pedro
Navarro-Compán, Victoria
Article History
First Online: 12 March 2019
Compliance with Ethical Standards
:
: EMAS was funded by Novartis Pharma AG. All authors have received honoraria for participating in EMAS from Novartis Pharma AG.Dr. Denis Poddubnyy has received unrelated research grants from Abbvie, MSD, Novartis, and Pfizer, and unrelated honoraria from Abbvie, BMS, Celgene, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, and UCB.Dr. Laure Gossec has received unrelated research grants from BMS, Lilly, and Pfizer and unrelated honoraria from Abbvie, BMS, Celgene, Janssen, Lilly, Novartis, MSD, Pfizer, and UCB.Dr. Christine Bundy has received unrelated honoraria from Abbvie, Celgene, Janssen, Lilly, Novartis, and Pfizer.Dr. Victoria Navarro-Compán has received unrelated honoraria or research grants from Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB.
: This article does not contain any studies with animal subjects. All participants were asked to provide explicit opt-in consent prior to participating in the EMAS survey. Participant data was anonymized.